List view / Grid view
4 February 2011 | By AstraZeneca
AstraZeneca announced today that the US FDA has acknowledged receipt of the company’s reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA)...
3 February 2011 | By NextPharma Technologies
NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce the appointment of Brigitte Genard as Quality Director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.
3 February 2011 | By Aesica Pharmaceuticals
Following the recent announcement that it has signed contracts ahead of acquiring three manufacturing sites from UCB, Aesica Pharmaceuticals has appointed a team...
3 February 2011 | By PwC
PwC has announced the appointment of Andrew Packman as head of the firm’s UK pharmaceutical and life sciences business...
2 February 2011 | By kdm communications limited
Plans include the generation and analyzing of sequence data, and to provide the samples and to host a new, free public database...
1 February 2011 | By The Scott Partnership
New measures will help drive down sponsor costs within clinical trials...
1 February 2011 | By Valeant Pharmaceuticals International Inc.
Valeant Pharmaceuticals International, Inc. and PharmaSwiss S.A. announced today that they have signed a binding agreement for Valeant to acquire PharmaSwiss...
1 February 2011 | By Karen Taylor PR
Jonathan Byrne has been appointed General Manager of Owen Mumford’s Cotswold Division...
1 February 2011 | By AstraZeneca
The European Commission has granted marketing authorisation to FLUENZ Influenza Vaccine...
31 January 2011 | By The Scott Partnership
Optibrium will be providing a sneak preview of the next generation of StarDrop at the Molecular Medicine Tri-Conference 2011...
31 January 2011 | By kdm communications limited
The reagents are initially being offered for sale in the USA, for use with the Infinite M1000 and Infinite 200 PRO series readers...
31 January 2011 | By Novartis
The FDA approval of Menveo for use in children 2 to 10 years of age is based on Phase III trial data involving 5,297 participants in that age group...
31 January 2011 | By Roche
Roche announced that the U.S. FDA approved Rituxan/MabThera as a maintenance treatment for patients with advanced follicular lymphoma...
28 January 2011 | By Bayer HealthCare
Bayer HealthCare and Zydus Cadila signed today an agreement in Mumbai, India, to form the Joint Venture Company Bayer Zydus Pharma...
Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its new informatics offerings within booth #2835 at PITTCON 2011, being held from March 13-18 at the Georgia World Congress Center in Atlanta.
